A Phase 2 Pilot Feasibility Study of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive Invasive Breast Carcinoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Jul 2015
At a glance
- Drugs Palbociclib (Primary)
- Indications Breast cancer; Male breast cancer
- Focus Therapeutic Use
- 15 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 May 2015 Planned number of patients changed from 120 to 160, as reported by ClinicalTrials.gov.
- 25 Feb 2014 New trial record